Blogs Contact Us Login
Media stay informed Investor relations News and press archive Media archive Resources Overview

Contact us:
Media Relation Investor & External Relations Mondobiotech holding AG
Das Kloster
Mürgstrasse 18
CH-6370 Stans - Switzerland

T +41 (0)840 200 010
F +41 (0)840 200 011

media@mondobiotech.com
April 2005
April 29, 2005 mondoBIOTECH and Bachem sign agreement for Thymopentin project
Basel-Gentilino and Bubendorf, Switzerland

mondoBIOTECH and Bachem sign a collaboration agreement for the development and production of Thymopentin

April 05, 2005 United States FDA grants Aviptadil the Orphan Drug Designation for Pulmonary Arterial Hypertension
Basel-Gentilino, Switzerland

United States FDA grants mondoBIOTECH's product Aviptadil the Orphan Drug Designation for the treatment of Pulmonary Arterial Hypertension.